ALK is a receptor tyrosine kinase first identified as a component of the nucleophosmin (NPM)-ALK fusion oncoprotein aberrantly expressed in anaplastic large cell lymphoma (ALCL) [14]. Here, ALK is linked to anaplastic large cell lymphoma.